Molnulup 200 Capsule
Marketer
Lupin Ltd
Salt Composition
Molnupiravir (200mg)
Overview Molnulup 200 Capsule
For adults with mild to moderate COVID-19, Molnulup 200mg capsules offer the first oral antiviral treatment. This medication inhibits viral replication, lessening the disease's severity and viral burden. Granted emergency authorization by Indian drug regulators on December 28, 2021, and subsequently by the U.S. FDA and UK authorities, it's intended for high-risk individuals with mild to moderate symptoms. Risk factors encompass obesity, age over 60, diabetes, and cardiac conditions. It's unsuitable for patients needing immediate hospitalization. The five-day oral course must be completed, even with symptom improvement. Potential side effects, including dizziness, headache, diarrhea, and nausea, should be reported to a physician. Prior to starting Molnulup 200mg capsules, disclose all pre-existing medical conditions and other medications to your doctor. Its use is not advised during pregnancy; pregnant or breastfeeding individuals should seek medical counsel before use.
Uses of Molnulup 200 Capsule
Managing mild to moderate cases of COVID-19
Major Benefits of Molnulup 200 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Molnulup 200 Capsules. These capsules can be ingested with or without food, however, consistent timing is recommended.
Common Side effects of Molnulup 200 Capsule:
- Nausea
- Dizziness
- Diarrhea
How to use Molnulup 200 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Molnulup 200 Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.
How Molnulup 200 Capsule works:
Molnupiravir 200mg capsules offer antiviral action by hindering SARS-CoV-2 replication. This mechanism prevents further viral production, thus reducing the overall viral burden within the patient.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Molnupiravir 200 mg capsules and alcohol is currently undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Molnulup 200 Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation and Molnulup 200 Capsule are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCONSULT YOUR DOCTOR
The effect of Molnulup 200 Capsule on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Molnupiravir 200 mg capsules can be administered to patients with renal impairment without modification of the prescribed dosage.
LiverSAFE IF PRESCRIBED
Molnulup 200 Capsules pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Molnulup 200 Capsule :
Omitting a scheduled Molnulup 200 Capsule requires contacting your physician.
Facts to Know About Molnulup 200 Capsule
| Label | Value |
|---|---|
| Chemical Type | Cytosine-containing Nucleotides |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Non-HIV antiviral medications |
3,018 People bought this recently